| Literature DB >> 33061313 |
Sophie de Boer1,2, Felix Klewitz1,2, Maximilian Bauer-Hohmann1,2, Lena Schiffer2,3, Uwe Tegtbur2,4, Lars Pape2,3, Mario Schiffer2,5,6, Martina de Zwaan1,2, Mariel Nöhre1,2.
Abstract
PURPOSE: After organ transplantation, adherence to immunosuppressive medication (ISM) is crucial to prevent organ rejection. To enable adherence, patients need to be well informed about the different aspects associated with their ISM. However, literature suggests that knowledge regarding ISM is often inadequate. PATIENTS AND METHODS: In a cross-sectional study, 702 patients after kidney transplantation participating in a structured multimodal follow-up program (KTx360°) were evaluated. We utilized a self-developed questionnaire which has been successfully used before to measure patients' knowledge about the ISM. Above that we aimed to evaluate potential associations between sociodemographic, medical, donation-specific, and psychosocial variables including adherence, levels of depression and anxiety, perceived social support, and cognitive functioning with the knowledge level.Entities:
Keywords: adherence; health literacy; immunosuppressive medication; kidney transplantation; renal transplantation
Year: 2020 PMID: 33061313 PMCID: PMC7524840 DOI: 10.2147/PPA.S269201
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
% of Patients Answering Each Item on the Immunosuppressant Knowledge Questionnaire (Correct Answers are Highlighted). Multiple Selections Were Allowed.
| Question | % of Patients Choosing the Answer | % of Patients who Answered the Question Correctly* |
|---|---|---|
| 80.2% | ||
Kiwi | 4.0% | |
Grapefruit | 91.6% | |
Chocolate | 4.6% | |
Coffee | 5.3% | |
Pomegranate | 26.8% | |
St. John’s wort | 53.7% | |
Banana | 7.5% | |
Peppermint tea | 1.4% | |
| 92.2% | ||
Before intake | 93.7% | |
During intake | 0.7% | |
After intake | 4.3% | |
Independent of intake | 1.7% | |
| 54.3% | ||
1–2 h before meals | 43.4% | |
Directly before meals | 13.5% | |
During meals | 16.0% | |
1–2 h after meals | 34.9% | |
More than 2 hours after meals | 9.1% | |
| 80.8% | ||
Skip the dosage completely | 44.3% | |
Quickly take the medication | 49.6% | |
Take twice the dosage | 0.3% | |
Measure blood level and decide afterward | 13.2% | |
| 55.3% | ||
Continue immunosuppressant intake as before | 66.7% | |
Immediately take another dosage | 0.1% | |
Take twice the dosage the next time | 0.9% | |
Measure blood level and decide afterward | 37.0% | |
| 78.5% | ||
Yes | 78.5% | |
No | 11.3% | |
| 64.5% | ||
Yes | 28.3% | |
No | 65.0% | |
| 61.5% | ||
Yes | 28.8% | |
No | 62.3% |
Note: *Questions were judged to be answered correctly if patients chose at least one correct answer without choosing a wrong answer at the same time.
Patient Characteristics
| Patient Characteristics | N=702 |
|---|---|
| Age in years | |
| Mean (SD) | 52.4 (14.2) |
| Median (IQR) | 54.6 (20.0) |
| Female sex, n (%) | 294 (41.9) |
| ≥12 years school attendance, n (%), (n=697) | 183 (26.1) |
| Living in a partnership, n (%), (n=697) | 464 (66.6) |
| German as first language, n (%), (n=641) | 572 (81.5) |
| Living donation, n (%) | 207 (29.5) |
| Time on dialysis in months | |
| Mean (SD) | 61.1 (49.7) |
| Median (IQR) | 55.5 (84) |
| Time since transplantation in months | |
| Mean (SD) | 65.1 (69.2) |
| Median (IQR) | 48.6 (78.2) |
| eGFR (mL/min/1.73 m2) at time of assessment (n=693) | |
| Mean (SD) | 45.8 (18.7) |
| Median (IQR) | 43.1 (24.4) |
| Diabetes mellitus, n (%) | 123 (17.5) |
| Hypertension, n (%) | 595 (84.8) |
| Coronary heart disease, n (%) | 79 (11.3) |
| HADS-D, Anxiety score (n=686) | |
| Mean (SD) | 5.1 (3.9) |
| Median (IQR) | 4.0 (6.0) |
| HADS-D, Depression score (n=688) | |
| Mean (SD) | 4.3 (3.9) |
| Median (IQR) | 3.0 (6.0) |
| F-SozU K7 score (n=687) | |
| Mean (SD) | 30.0 (6.0) |
| Median (IQR) | 32.0 (8.0) |
| MARS-D score (n=687) | |
| Mean (SD) | 24.4 (1.2) |
| Median (IQR) | 25.0 (1.0) |
| Knowledge test % | |
| Mean (SD) | 70.9 (18.0) |
| Median (IQR) | 75.0 (25.0) |
Abbreviations: eGFR, estimated glomerular filtration rate; F-SozU K7, Questionnaire for Perceived Social Support; HADS-D, Hospital Anxiety and Depression Scale; IQR, interquartile range; MARS-D, Medication Adherence Report Scale; SD, standard deviation.
Correlational Analyses of the Knowledge Test Score Using Spearman Correlations
| Knowledge Test (% of Correctly Answered Questions) | |
|---|---|
| Age (years) | r=0.015, p=0.70 |
| time since transplantation (months) | r=−0.036, p=0.34 |
| eGFR (mL/min/1.73 m2) | r=0.047, p=0.22 |
| HADS-D, Anxiety score (n=685) | r=−0.011, p=0.77 |
| HADS-D, Depression score (n=687) | r=−0.062, p=0.11 |
| F-SozU K7 score (n=686) | r=0.031, p=0.42 |
| MARS score (n=686) | r=−0.021, p=0.58 |
| Time on dialysis (n=690) | r=−0.074, p=0.051 |
Abbreviations: eGFR, estimated glomerular filtration rate; F-Sozu K7, Questionnaire for Perceived Social Support; HADS-D, Hospital Anxiety and Depression Scale; MARS-D, Medication Adherence Report Scale.
Comparison of Knowledge Test Scores Between Dichotomous Variables
| Knowledge Test (% of Correctly Answered Questions) | |||
|---|---|---|---|
| N | Mean (SD) | Statistics | |
| Sex | |||
| Female | 294 | 72.4 (18.8) | Z=−2.000, p=0.036, |
| Male | 408 | 69.8 (17.4) | |
| Partnership status | |||
| In a partnership | 464 | 72.2 (17.4) | Z=−2.330, p=0.02, |
| No partnership | 233 | 68.6 (19.0) | |
| Educational level | |||
| ≥12 years | 183 | 71.1 (17.1) | Z=−0.162, p=0.87 |
| <12 years | 514 | 71.0 (18.3) | |
| Type of donation | |||
| Living donor | 207 | 72.5 (17.7) | Z=−1.333, p=0.18 |
| Deceased donor | 495 | 70.3 (18.2) | |
| Cognitive impairment | |||
| DemTect ≥13 | 559 | 72.0 (17.0) | Z=−2.160, p=0.03, |
| DemTect <13 | 105 | 66.7 (21.1) | |
| First language | |||
| German | 572 | 71.7 (17.2) | Z=−2.744, p=0.006, |
| Other | 69 | 63.9 (22.8) | |
Linear Regression Analysis
| Variables | N | β | T | p-value | R2 |
|---|---|---|---|---|---|
| 583 | 0.048 | ||||
| Sex | −0.086 | −2.083 | p=0.038 | ||
| First language | −0.113 | −2.760 | p=0.006 | ||
| Partnership status | 0.113 | 2.749 | p=0.006 | ||
| Cognitive impairment | −0.064 | −1.545 | p=0.123 | ||
| Depression (HADS-D) | −0.049 | −1.195 | p=0.233 | ||
| Time on dialysis (months) | −0.075 | −1.831 | p=0.068 |
Abbreviation: HADS-D, Hospital Anxiety and Depression Scale.